Calumet, Inc.
NASDAQ:CLMTOil & Gas Exploration & Production
-$1.21 today
- Market cap
- $2.67B
- Beta
- 0.72
- P/E (TTM)
- -14.7
- EPS (TTM)
- -$2.17
Volume 1.74M
Average 1.11M
CLMT Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Calumet, Inc.NASDAQ: CLMT
Accounts Receivables · Q3 FY2026 · quarter ended Sep 2026
Accounts receivables turns negative
Q3 FY2026 accounts receivables was -$49.1M, compared with $0 a year earlier. Trailing-twelve-month accounts receivables was -$234.6M.
Context
- Accounts receivables amounted to 1.1% of revenue in FY2025, up 0.9 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near -$49.1M or moves back toward the trailing-twelve-month quarterly average of -$58.65M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 47M USD
- Year-over-year change
- +487.5%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 47M | +487.5% |
| FY2024 | 2024-12-31 | 8M | +141.7% |
| FY2023 | 2023-12-31 | (19.2M) | -36.2% |
| FY2022 | 2022-12-31 | (14.1M) | +84.6% |
| FY2021 | 2021-12-31 | (91.4M) | — |
Accounts Receivables vs competitors
How CLMT compares with its peers on the latest reported figures
- CLMT's LTM Sep 2026 accounts receivables of $234.6M is the largest of the 11 companies compared; the peer median is $10.57M.
- Accounts receivables amounts to 4.5% of revenue for CLMT, versus a peer median of 0.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $234.6M | — | — | 4.5% | |
| LTM Jun 2026 | $91.2M | +328.2% | — | 5.0% | |
| LTM Sep 2026 | $53.27M | -696.2% | — | 2.6% | |
| LTM Aug 2026 | $26.47M | -68.4% | +8.1% | 0.3% | |
| LTM Mar 2026 | $17.88M | +8.9% | — | 0.8% | |
| LTM Jun 2026 | $15M | -61.5% | +5.2% | 0.3% | |
| LTM Jun 2026 | $10.65M | — | -47.4% | 0.4% | |
| LTM Jun 2026 | $10.49M | -46.7% | +4.0% | 1.4% | |
| LTM Mar 2026 | $5.44M | -129.7% | +57.9% | 4.9% | |
| LTM Sep 2026 | $5.1M | -54.9% | — | 0.5% | |
| LTM Jun 2026 | $1M | -98.5% | — | 0.0% | |
| Peer median (excluding CLMT) | $10.57M | -61.5% | +5.2% | 0.6% | |
Competitors are the stored peer set for CLMT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (260.1M) | (169.8M) | 48.1M | (222M) | (33.8M) |
| Depreciation & Amortization | 107.7M | 98.3M | 146.8M | 149M | 148.8M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 50.7M | 0 | 14.7M | 14.6M | (4.5M) |
| Change in Working Capital | (45.1M) | (189.5M) | (25.1M) | 10.2M | (3.1M) |
| Accounts Receivables | (91.4M) | (14.1M) | (19.2M) | 8M | 47M |
| Inventory | (27M) | (190.5M) | 25.1M | 16.1M | 14.9M |
| Accounts Payables | 71M | 56.9M | (12.4M) | 1.7M | (52.2M) |
| Other Working Capital | 2.3M | (41.8M) | (18.6M) | (15.6M) | (12.8M) |
| Other Non-Cash Items | 102.8M | 361.6M | (199.4M) | 1.8M | 1.5M |
| Operating Cash Flow | (44M) | 100.6M | (14.9M) | (46.4M) | 108.9M |
| Capital Expenditures | (82.9M) | (536.2M) | (271.8M) | (76.7M) | (52.3M) |
| Acquisitions (Net) | 0 | 250.2M | 0 | 0 | 96.9M |
| Purchases of Investments | 0 | 0 | 0 | 0 | (500K) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 100K | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (82.8M) | (286M) | (271.8M) | (76.7M) | 44.1M |
| Debt Repayment | 41.4M | (254.2M) | 248.7M | 97.7M | (86.8M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (4.4M) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 97.9M | 357.3M | 17.5M | 56.6M | 93M |
| Financing Cash Flow | 139.3M | 98.7M | 266.2M | 154.3M | 6.2M |
| Effect of Forex Changes | 0 | 83.8M | 0 | 0 | 0 |
| Net Change in Cash | 12.5M | (2.9M) | (20.5M) | 31.2M | 159.2M |
| Free Cash Flow | (126.9M) | (435.6M) | (286.7M) | (123.1M) | 56.6M |
Calumet, Inc.
NASDAQ:CLMT
Intrinsic Alpha fair value
Locked
Current Price
$30.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.